Etilevodopa

Chemical compound
  • N04BA06 (WHO) (combination with decarboxylase inhibitor)
Identifiers
  • ethyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate
CAS Number
  • 37178-37-3 checkY
PubChem CID
  • 170345
ChemSpider
  • 148944 checkY
UNII
  • 895X917GYE
KEGG
  • D04097 checkY
CompTox Dashboard (EPA)
  • DTXSID10905092 Edit this at Wikidata
ECHA InfoCard100.223.003 Edit this at WikidataChemical and physical dataFormulaC11H15NO4Molar mass225.244 g·mol−13D model (JSmol)
  • Interactive image
  • O=C(OCC)[C@@H](N)Cc1cc(O)c(O)cc1
InChI
  • InChI=1S/C11H15NO4/c1-2-16-11(15)8(12)5-7-3-4-9(13)10(14)6-7/h3-4,6,8,13-14H,2,5,12H2,1H3/t8-/m0/s1 checkY
  • Key:NULMGOSOSZBEQL-QMMMGPOBSA-N checkY
  (verify)

Etilevodopa (TV-1203) is a dopaminergic agent which was developed as a treatment for Parkinson's disease.[1] It is the ethyl ester of levodopa. It was never marketed.

See also

  • Melevodopa

References

  1. ^ Djaldetti R, Giladi N, Hassin-Baer S, Shabtai H, Melamed E (November–December 2003). "Pharmacokinetics of etilevodopa compared to levodopa in patients with Parkinson's disease: an open-label, randomized, crossover study". Clinical Neuropharmacology. 26 (6): 322–6. doi:10.1097/00002826-200311000-00012. PMID 14646613. S2CID 23992241.
  • v
  • t
  • e
Dopaminergics
DA precursors
DA receptor agonists
MAO-B inhibitors
COMT inhibitors
AAAD inhibitors
AnticholinergicsOthers
  • v
  • t
  • e
D1-like
Agonists
PAMs
Antagonists
D2-like
Agonists
Antagonists
  • See also: Receptor/signaling modulators
  • Adrenergics
  • Serotonergics
  • Monoamine reuptake inhibitors
  • Monoamine releasing agents
  • Monoamine metabolism modulators
  • Monoamine neurotoxins
  • v
  • t
  • e
Phenethylamines


Stimulants: Phenylethanolamine

Amphetamines
Phentermines
Cathinones
Phenylisobutylamines
Phenylalkylpyrrolidines
Catecholamines
(and close relatives)
Miscellaneous
Stub icon

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e